CompletedPhase 4

Ferritin Screening And IRon Treatment for Maternal Anemia and FGR Prevention Trial

Pakistan600 participantsStarted 2020-01-14

Plain-language summary

Prevalence of anemia in Asia is more than 50%. All woman who book for antenatal care with non-anaemic iron deficiency (NAID) can be offered therapeutic doses of parentral iron, as a directly observed complete therapy, to prevent of maternal anaemia and fetal growth restriction. The investigators will compare this intervention with usual care in a multicentre randomised trial.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non-anaemic iron deficiency Exclusion Criteria: * Anaemia or normal iron stores

What they're measuring

Maternal anaemia

Timeframe: 36 weeks' gestation

Trial details

NCT IDNCT04228627

SponsorServices Institute of Medical Sciences, Pakistan

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2024-01-30

View on ClinicalTrials.gov More Iron Deficiency (Without Anemia) trials